Back to the program

Contributed Papers

Considerations in Clinical Trial Designs

Tue, Aug 6, 8:30 AM - 10:20 AM

Binbing YuChair

Biopharmaceutical Section

6 Presentations

Addressing Missing Data in Late-Stage Clinical Trials by Incorporating the Reason for Missingness

8:35 AM - 8:50 AM

Jitendra Ganju (Ganju Clinical Trials, LLC)

Co-authors: Ron Yu (Gilead Sciences)

Development of an alpha allocation method based on likelihood and utility in multi-arm trials

8:50 AM - 9:05 AM

Empirical simulation for complex clinical trial data in drug development

9:05 AM - 9:20 AM

Yuxin Ding (Eli Lilly and Company)

Co-authors: Yushi Liu, Yongming Qu (Eli Lilly and Company)

New approaches to demonstrate efficacy of treatments in clinical trials

9:20 AM - 9:35 AM

Bob Zhong (Regeneron Pharmaceuticals)

Stepwise gatekeeping procedures for multiplicity problems involving two sequences of hypotheses

9:35 AM - 9:50 AM

Subgroup Analyses in Cluster-Randomized Trials Based on Aggregated Predictors

9:50 AM - 10:05 AM

Brian Williamson (Kaiser Permanente Washington Health Research Institute)

Co-authors: Yates Coley (Kaiser Permanente Washington Health Research Institute), Clarissa Hsu (Kaiser Permanente Washington Health Research Institute), Courtney McCracken (Kaiser Permanente Georgia), Andrea Cook (Kaiser Permanente Washington Health Research Institute)

↑